JMJD3 and UTX as key targets for gene-modified mesenchymal stem cell therapy in cartilage tissue engineering

Molecular Therapy 2026 Open access

Read full text
Authors: Lyess Allas, Juliette Aury‐Landas, Quitterie Briet-Rochoux, Anaïs Julien, Eva Lhuissier, Marion Lenté, Sybille Brochard, A. Veyssière, Karim Boumédiene, Catherine Baugé
DOI: 10.1016/j.ymthe.2026.01.018
Cited by: 1
References: 25

Fields of Study & Subjects

Osteoarthritis Treatment and Mechanisms Mesenchymal stem cell research Epigenetics and DNA Methylation

Publication details

Journal / source
Molecular Therapy
Publisher
Elsevier BV
Volume
34
Issue
5
Pages
2740–2753
Publication date
21 January 2026
Language
EN